DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 0.00 0.00%
S&P 500 2,086.24 25.22 1.22%
market minute promo

Pfizer (NYSE: PFE)

35.00 0.47 (1.36%)

REAL-TIME: Last trade at

Extended Hours: $34.85 -$0.15 (-0.43%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

PFE $35.00 1.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.60
Previous Close $34.53
Daily Range $34.55 - $35.22
52-Week Range $27.51 - $35.45
Market Cap $214.5B
P/E Ratio 24.49
Dividend (Yield) $1.12 (3.2%)
Ex-Dividend Date
Dividend Pay Date
02/04/15
03/03/15
Volume 25,502,833
Average Daily Volume 28,252,319
Current FY EPS $2.08

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years

Big Pharma stocks often have deep product pipelines, substantial cash flow, and healthy dividends, but they are far from created equal. With patent expirations taking their toll, this would appear to be the one Big Pharma stock you can trust over the next decade.

Hospira Presents Data on Retacrit, an Epogen Biosimilar - Analyst Blog

3 Stocks Improving Performance Of The Drugs Industry

XLV, DXGE: Big ETF Inflows

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Could These Experimental Drugs Eclipse Harvoni's Historic Launch?

Harvoni set the standard for blockbuster drug launches -- but these three drugs just might have a shot at being even bigger.

US IPO Weekly Recap: SolarEdge shines while other IPOs fall flat

After Hours Most Active for Mar 26, 2015 : V, BAC, BBD, WFC, PFE, HOT, GMCR, QQQ, CMCSA, FB, CSCO,

After Hours Most Active for Mar 26, 2015 : V, BAC, BBD, WFC, PFE, HOT, GMCR, QQQ, CMCSA, FB, CSCO, AAPL

Johnson & Johnson’s EPS Will Rise, But Here Are The Risks

Should Investors Toss in the Towel on Amarin Corp Plc?

Awash with possibilities a decade ago, Amarin ultimately fell as low as $1 per share; tune in to find out what happened.

See More PFE News...

PFE's Top Competitors

PFE $35.00 (1.36%)
Current stock: PFE
JNJ $101.55 (1.21%)
Current stock: JNJ
ROG $81.93 (1.94%)
Current stock: ROG
GSK $47.20 (0.38%)
Current stock: GSK